The minimum recommended waiting period is six weeks postpartum for uncomplicated vaginal deliveries
FDA-approved only as a clinician-placed 16 mg EPP implant, not as self-injection
Scientific and institutional sources All figures and dates cited in this comparison are based on published clinical trials and the following official opinions, verified on May 8, 2026
Studies have found GLP-1 receptors in the kidney itself.3 The protective effects include: reducing inflammation in kidney tissue, lowering blood pressure (by about 5-7 mmHg), improving how kidneys filter blood, and reducing protein leakage into urine an early warning sign of kidney damage.4 THE BIGGER PICTURE: 85,000+ PATIENTS A major meta-analysis of 11 clinical trials with 85,373 patients confirmed the kidney benefits
Treatments that are effective (singly or in combination) should be continued
Rybelsus is the pill version of semaglutide -- the active ingredient that helps patients lose weight -- and is already approved for those with Type 2 diabetes